CN¥8.86+140.76% · 3M
Moving avg
1W+29.53%
1M+97.33%
3M+143.41%
6M+156.81%
YTD+152.42%
1Y+127.18%
3Y+160.59%
5Y+166.07%
52-week range
$0.42100% of range$0.94
Company health
Value3/6
Growth1/6
Profitability3/6
Health4/6
Dividend2/6
Bull vs bear
Strengths
- High return on equity (543%)
- Net cash on the balance sheet
Risks
- Richly valued at 47.0x earnings
Key statistics
Valuation
Market cap
$3.31B
Enterprise value
$2.08B
P/E ratio (TTM)
47.01x
P/S ratio (TTM)
0.91x
EV/EBITDA
18.91x
Per share & returns
EPS (TTM)
$0.02
Dividend yield
0.00%
Beta (1Y)
0.14
30-day change
+97.33%
Trading
Volume (24h)
505.92M
Previous close
CN¥8.81
Shares outstanding
2.52B
About Harbin Pharmaceutical Group Co., Ltd.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
SSE
Symbol
600664.SS
Harbin Pharmaceutical Group Co., Ltd. is a mid-cap healthcare company in the Drug Manufacturers - Specialty & Generic industry. Its shares are listed on SSE (China) and trade under the ticker 600664.SS.
Frequently asked questions
What is Harbin Pharmaceutical Group Co., Ltd.'s market cap?
Harbin Pharmaceutical Group Co., Ltd. (600664.SS) has a market capitalization of $3.31B.
What is Harbin Pharmaceutical Group Co., Ltd.'s P/E ratio?
Harbin Pharmaceutical Group Co., Ltd. trades at a price-to-earnings (P/E) ratio of 47.01.
What exchange does 600664.SS trade on?
600664.SS trades on SSE.
Appears in
Eli Lilly and CompanyLLY
$1,220.72+0.04%
$1.15T cap
Johnson & JohnsonJNJ
$261.31+0.17%
$629.74B cap
AbbVie Inc.ABBV
$250.53+0.71%
$442.63B cap
UnitedHealth Group IncorporatedUNH
$402.71-0.71%
$365.71B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$355.30B cap
Merck & Co., Inc.MRK
$134.73+1.36%
$332.76B cap
Novartis AGSWX: NOVN
CHF 123.96-0.19%
$290.28B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.27B cap